Navigation Links
MEI Development Corporation and GE Healthcare Sign Strategic Agreement
Date:5/18/2009

GE's Sole-Source Agreement Spans MEI's Broad Solution Offerings

CORAL SPRINGS, Fla., May 18 /PRNewswire/ -- MEI Development Corporation (MEI), a subsidiary of The MEI Healthcare Group, announced today a strategic agreement with GE Healthcare (NYSE: GE), a leading provider of healthcare technology. The sole-source, strategic agreement offers GE Healthcare's customers the option of MEI's broad solutions, including development, financial, oncology, women's health and consulting services.

"Our partnership with MEI provides a single, seamless platform for a comprehensive imaging solution," said Bob White, Senior Vice President, GE Healthcare. "When customers are provided with a robust, scalable model under one platform, the quality and cost of healthcare delivery improves."

"Our agreement ensures that MEI will continue to provide physician and hospital clients with seamless access to GE's industry-leading technology, which is fundamental to delivering MEI's comprehensive solution portfolio," said Gordon Baltzer, President and CEO of The MEI Healthcare Group.

MEI Development Corporation provides turnkey solutions for physicians, outpatient facilities and hospitals that are interested in adding and updating imaging technology. MEI offers a unique array of services including determining project viability, creation and implementation of business planning, procurement of imaging equipment and complete project financing.

About MEI: The MEI Healthcare Group, LLC, headquartered in Coral Springs, Florida, is a healthcare strategy firm that works with physician groups and medical centers to provide turnkey healthcare solutions for imaging and radiation therapy services.

About GE Healthcare: GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care. Our broad expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, drug discovery, biopharmaceutical manufacturing technologies, performance improvement and performance solutions services help our customers to deliver better care to more people around the world at a lower cost. In addition, we partner with healthcare leaders, striving to leverage the global policy change necessary to implement a successful shift to sustainable healthcare systems.

Our "healthymagination" vision for the future invites the world to join us on our journey as we continuously develop innovations focused on reducing costs, increasing access and improving quality and efficiency around the world. Headquartered in the United Kingdom, GE Healthcare is a $17 billion unit of General Electric Company (NYSE: GE). Worldwide, GE Healthcare employs more than 46,000 people committed to serving healthcare professionals and their patients in more than 100 countries. For more information about GE Healthcare, visit our website at www.gehealthcare.com

    CONTACT:
    Nick Wasmiller
    Seyferth & Associates Inc.
    1-800-435-9539
    wasmiller@seyferthpr.com


'/>"/>
SOURCE MEI Development Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. BioMarin Receives 2009 Corporate Award for the Development of Kuvan
2. Kinovate Life Sciences, Inc. and Nitto Denko Corporation Announce Successful Development of NittoPhase™ HL High Loading Solid Support for Oligonucleotide Synthesis
3. arc Thrift Stores to Honor Individuals and Businesses Who Support People With Developmental Disabilities
4. Oxygen Biotherapeutics, Inc. Signs Cooperative Research and Development Agreement With Naval Medical Research Center and Walter Reed Army Institute of Research
5. iJET Provides Additional Services in Response to Ongoing H1N1 Influenza A (Swine Flu) Developments
6. Recent developments at Burnham Institute for Medical Research, May 2009
7. VIDEO from Medialink and the Society of Interventional Radiology: Prostate and Kidney Cancer - New Life-Changing Developments
8. Interleukin Genetics to Chair Expert Panel Discussion on Use of Biomarkers in Drug Development at BIO Convention
9. Cardium Reports on First Quarter 2009 Financial Results and Recent Developments
10. Children's Hospital Boston Advances Cutting-Edge Technologies with its New Technology Development Fund
11. Prematics Names S. Michael Ross Chief Medical Officer and Senior Vice President of Business Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are sharpening their ... Award, an essay contest in which patients and their families pay tribute to a ... the 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. ...
(Date:6/24/2016)... Vegas, Nevada (PRWEB) , ... June 24, 2016 ... ... Las Vegas client, The Grove Investment Group (TGIG), has initiated cultivation and processing ... Grove, in Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of ...
(Date:6/24/2016)... ... June 24, 2016 , ... Venture Construction Group (VCG) sponsors Luke’s ... June 20th at the Woodmont Country Club at 1201 Rockville Pike, Rockville, Maryland, 20852. ... helping service members that have been wounded in battle and their families. Venture Construction ...
(Date:6/24/2016)... ... June 24, 2016 , ... Finally, a bruise cream that ... dermaka cream can be incorporated into the post-surgical treatment plans of a variety of ... , dermaka cream is very effective for bruising and causes a rapid resolution of ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Today, ... optimize the ingestion of their medication by matching users with high quality water pipes ... compare pieces with no commitment. , Inhale was founded by two brothers, Nick and ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 Any dentist who ... challenges of the current process. Many of them do not ... the technical difficulties and high laboratory costs involved. And those ... offer it at such a high cost that the majority ... Dr. Parsa Zadeh , founder of Dental ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
(Date:6/23/2016)... BOGOTA, Colombia , June 23, 2016  Astellas today announced the establishment of Astellas Farma Colombia (AFC), a ... second affiliate in Latin America . ... ... ... ...
Breaking Medicine Technology: